ESMO 2025: Bayer and BI neck and neck in first line HER2+ NSCLC
On 18 October 2025 at the European Society of Medical Oncology, held in Berlin, Germany, from 17 to 21 October, two important datasets were read out in first-line metastatic non-small cell lung cancer (NSCLC) with human epidermal growth factor receptor 2 ( …